Combined Hepatitis C Virus Antigen (HCV Antigen), Recombinant
| Full Name |
Combined Hepatitis C Virus Antigen (HCV Antigen), Recombinant
|
Abbreviated Name-1 |
Combined Hepatitis C Virus (HCV); |
| Documents |
| Figures |
| Reference |
|---|
Bortolotti F, et al. Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome. Gut. Jun 2005; 54(6): 852-857.
Boni S, et al. Hepatitis C virus core protein acts as a trans-modulating factor on internal translation initiation of the viral RNA. J. Biol. Chem. May 2005; 280(18): 17737-17748.
Bair RM, et al. Prevalence and risk factors for hepatitis C virus infection among adolescents in detention. Archives of pediatrics & adolescent medicine. Nov 2005; 159(11): 1015-1018.
|
|
Description |
E. coli derived recombinant. Combined Hepatitis C Virus (HCV) contains the HCV nucleocapsid, NS3, NS4, and NS5 immunodominant regions. Sequences from 4 gene products (proteins) of the hepatitis C virus (HCV) were scanned by using 3 different PCR-based techniques in search of the most immunoreactive regions suitable for the development of a diagnostic test for the detection of anti-HCV in human sera. The most diagnostically relevant proteins identified in this study were then contructed into one recombinant antigen. |
Source |
E. coli |
Purity |
Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
Storage |
Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
Concentration |
1 mg/ ml in 50 mM Na-PO4, pH 8.5, 2.4 mM EDTA, 5 mM DTT,0.1% SDS. |
Stability |
Five years frozen. 24 hrs in solution at room temperature. |
Specificity |
Immunoreactive with sera of HCV- infected individuals. |
Applications |
Antigen in ELISA and Western blots, excellent antigen for detection of HCV with minimal specificity problems. |
Note |
; |
Related Products
 |
1 |
Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 . |
2 |
Bacterial Expression System: GenScript has developed BacPowerTM technologies to tackle hard-to-express and hard-to-dissolve proteins. |
3 |
Yeast Expression System: GenScript's proprietary YeastHIGHTM technology combines the advantages of the bacterial and eukaryotic expression systems. |
4 |
Baculovirus/Insect Cell Expression System: GenScript developed BacuVanceTM platform for the secretion of recombinant proteins from baculovirus-infected insect cells. |
5 |
Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level. |
|